Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 21, 2015; 21(43): 12274-12282
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12274
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12274
Status | Tissue type | Control | Aberrant microRNA expression | Ref. |
Inactive UC | Colon, nonspecific, n = 8 | Inactive CD | Decreased: miR-100a-3p, 100b-5p, 150, 196b, 223 and 320a | Fasseu et al[19], 2010 |
Active or inactive UC | Colon, distalmost, n = 12 | Active or Inactive CD | Increased: miR-19b, 23b, 106a, 191 and 629 | Lin et al[35], 2013 |
Active UC | Peripheral blood, n = 13 | Active CD | Increased: miR-3180-3p, plus-E1035 and plus-F1159 | Wu et al[31], 2011 |
- Citation: Fisher K, Lin J. MicroRNA in inflammatory bowel disease: Translational research and clinical implication. World J Gastroenterol 2015; 21(43): 12274-12282
- URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12274.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i43.12274